Following on from our webinar earlier in the year titled ‘Why you should take advantage of the AI (7240) and adopt the new GS1 Clinical Trial barcode standards,’ we wanted to pick out five key points that were covered that will help you to understand the new GS1 Clinical Trial barcodes standards in more detail (if you haven’t had a chance to watch the webinar, you can watch it here.)
Here are five key points:
- The overwhelming majority of attendees (93.8%) said they have not adopted the new GS1 clinical trial barcode standards – although the standards are not currently mandatory, we know that industry leaders such as Sanofi and Pfizer are leading the way having already adopted the new GS1 standards. Large industry leaders adopting these GS1 standards sets a clear example to the rest of the market and could give a hint that the industry will soon need to follow suit.
- Key to ensuring the right patient receives the right drug at the right time – the ultimate aim of these GS1 standards is to ensure patient safety. Removing data input errors can allow human errors to be eliminated, leading to improved patient safety. Real time tracking of products in the field will also allow for quick action to be taken should any errors occur.
- This is not a standard that has been imposed on the industry – over nine months, 60 professionals from 37 Clinical Trials Organizations came together to work on these new standards. This is critical, as it shows that this is clearly the way the industry wants to work going forward.
- Audit your current labeling software/operation – are you able to generate a 2d data matrix? Does it contain latest AI 7240 and 8006? Will your system be compatible with latest Windows systems? These are all questions that you will need to answer if you are looking to adopt the new GS1 standard. If your system is unable to do any of the above, you may want to think about updating your labeling software to a system that can.
- Adopting this standard will future proof your labeling processes. Get ahead of the game before it is made mandatory. Apply a touch it once approach. Ask if your IT department are looking to update operating systems, it could be a good opportunity to update your labeling software at the same time. The Medical Device industry struggled with implementing the EU MDR and UDI regulations, with businesses not getting their operations in line to meet regulation deadlines. Now could be a good time to review your processes and adopt the GS1 standard before it becomes a mandatory requirement.
We hope you have found these five key points worthwhile, but if you would like more information on the GS1 standard, please don’t hesitate to contact us.
About the author
Jack Cowmeadow, Senior Marketing Executive, PRISYM ID
I’m Jack Cowmeadow, and as part of the marketing team here at PRISYM ID, I have a keen interest in researching and analyzing the key facts, figures and market trends within life science, pharma and medical device labeling. While this research is valuable to my everyday work, it’s great to share this information as part of our blog.